Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-24 @ 4:07 PM
NCT ID:
NCT01909466
Eligibility Criteria:
Inclusion Criteria:
* Male and female individuals between 18 and 64 years, inclusive, at the time of informed consent.
* Prior history of tolerating aripiprazole per investigator's judgement.
Exclusion Criteria:
* Subjects who have met DSMV-IV-TR criteria for substance dependence within the past 180 days.
* Subjects who use more than one antipsychotic medication at screening.
* Use of any CYP2D6 and CYP3A4 inhibitors, or CYP3A4 inducers within 14 days prior to dosing and for the duration of the trial.
* Subjects who participated in any clinical trial involving a psychotropic medication within 1 month prior to enrollment.
* Subjects currently in an acute relapse of schizophrenia.
* Subjects with a current DSMV-IV-TR diagnosis other than schizophrenia.
* Subjects who are considered treatment-resistant to antipsychotic medications.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT01909466
Study Brief:
Protocol Section:
NCT01909466